198 related articles for article (PubMed ID: 21852700)
1. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
2. Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.
Geraghty J; Butler P; Seaman H; Snowball J; Sarkar S; Blanks R; Halloran S; Bodger K; Rees CJ
Br J Cancer; 2014 Nov; 111(11):2156-62. PubMed ID: 25225905
[TBL] [Abstract][Full Text] [Related]
3. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
4. Symptoms do not predict colorectal cancer in an FOB screened population.
Saldanha JD; Moug SJ; Linton K; Diament RH
Scott Med J; 2013 May; 58(2):95-8. PubMed ID: 23728754
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
[TBL] [Abstract][Full Text] [Related]
7. Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?
Lee TJ; Hull MA; Rajasekhar PT; Clifford GM; Ritchie M; James P; McNally RJ; Rutter MD; Rees CJ
Digestion; 2012; 85(4):278-81. PubMed ID: 22538301
[TBL] [Abstract][Full Text] [Related]
8. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
[TBL] [Abstract][Full Text] [Related]
9. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
[TBL] [Abstract][Full Text] [Related]
10. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
[TBL] [Abstract][Full Text] [Related]
11. The positive predictive value of guaiac faecal occult blood test in relation to the number of positive squares in two consecutive rounds of colorectal cancer screening.
Manfredi S; Philip J; Campillo B; Piette C; Durand G; Riou F; Bretagne JF
Eur J Cancer Prev; 2011 Jul; 20(4):277-82. PubMed ID: 21633201
[TBL] [Abstract][Full Text] [Related]
12. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
[TBL] [Abstract][Full Text] [Related]
13. The first 2 years of colorectal cancer screening in Ferrara, Italy.
Matarese VG; Feo CV; Lanza G; Fusetti N; Carpanelli MC; Cataldo S; Cifalà V; Ferretti S; Gafà R; Marzola M; Montanari E; Palmonari C; Simone L; Trevisani L; Stockbrugger R; Gullini S
Eur J Cancer Prev; 2011 May; 20(3):166-8. PubMed ID: 21445018
[TBL] [Abstract][Full Text] [Related]
14. Medications with anticoagulant properties increase the likelihood of a negative colonoscopy in faecal occult blood test population screening.
Clarke P; Jack F; Carey FA; Steele RJ
Colorectal Dis; 2006 Jun; 8(5):389-92. PubMed ID: 16684082
[TBL] [Abstract][Full Text] [Related]
15. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
17. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
18. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
19. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
